From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival?

被引:13
作者
Tarzia, Vincenzo [1 ]
Di Giammarco, Gabriele [2 ]
Di Mauro, Michele
Bortolussi, Giacomo [1 ]
Maccherini, Massimo [3 ]
Tursi, Vincenzo [4 ]
Maiani, Massimo [4 ]
Bernazzali, Sonia [3 ]
Marinelli, Daniele [2 ]
Foschi, Massimiliano [2 ]
Buratto, Edward [1 ,2 ]
Bejko, Jonida [1 ]
Gregori, Dario [1 ]
Scuri, Silvia [1 ]
Livi, Ugolino [4 ]
Sani, Guido [1 ,3 ]
Bottio, Tomaso [1 ]
Gerosa, Gino [1 ]
机构
[1] Univ Padua, Cardiac Surg, I-35128 Padua, Italy
[2] Univ G dAnnunzio, Cardiac Surg, Chieti, Italy
[3] Univ Siena, Cardiac Surg, I-53100 Siena, Italy
[4] Univ Udine, Cardiac Surg, I-33100 Udine, Italy
关键词
ventricular assist device; LVAD; Jarvik; 2000; bearing system; heart failure; follow-up; MECHANICAL CIRCULATORY SUPPORT; HEMOLYSIS; MODELS; HEART; RISK; PIN;
D O I
10.1016/j.jtcvs.2015.09.107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In vitro tests demonstrated that the new cone-bearing configuration of the Jarvik 2000 (Jarvik Heart Inc, New York, NY) left ventricular assist device exhibits better hydraulic efficiency than the previous pin-bearing design. We investigated the long-term outcomes of patients who received the Jarvik 2000 left ventricular assist device, depending on bearing design. Methods: A retrospective review of prospectively collected data from 18 centers included in the Italian Registry was performed. From May 2008 to September 2013, 99 patients with end-stage heart failure were enrolled. Patients were divided into 2 groups according to their Jarvik 2000 suspending mechanism: Group pin included patients with pin bearings (May 2008 to June 2010), and group cone included patients with newer cone bearings (July 2010 to September 2013). The 2 groups did not differ significantly in terms of baseline characteristics. Results: A total of 30 of 39 patients (group pin) and 46 of 60 patients (group cone) were discharged. During follow-up, 6 patients underwent transplantation, and in 1 patient the left ventricular assist device was explanted. The cumulative incidence competing risk of the entire cohort for noncardiovascular-related death was 28% (20%-40%); the cumulative incidence competing risk for cardiovascular-related death was 56% (42%-73%): 71% in group pin versus 26% in group cone (P = .034). The multivariate analyses confirmed that the pin-bearing design was a risk factor for cardiovascular death, along with Interagency Registry for Mechanically Assisted Circulatory Support class. Right ventricular failures and ischemic and hemorrhagic strokes were significantly higher in group pin. Conclusions: Patients with the new pump configuration showed a better freedom from cardiovascular death and lower incidence of fatal stroke and right ventricular failure. Further studies are needed to prove the favorable impact of pump-enhanced fluid dynamics on long-term results.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 18 条
[1]   Ambient hemolysis and activation of coagulation is different between Heart Mate II and Heart Ware left ventricular assist devices [J].
Birschmann, Ingvild ;
Dittrich, Marcus ;
Eller, Thomas ;
Wiegmann, Bettina ;
Reininger, Armin J. ;
Budde, Ulrich ;
Strueber, Martin .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (01) :80-87
[2]   Hemolysis: A harbinger of adverse outcome after Left ventricular assist device implant [J].
Cowger, Jennifer A. ;
Romano, Matthew A. ;
Shah, Palak ;
Shah, Neha ;
Mehta, Vivek ;
Haft, Jonathan W. ;
Aaronson, Keith D. ;
Pagani, Francis D. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (01) :35-43
[3]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[4]   Less Invasive Surgical and Perfusion Technique for Implantation of the Jarvik 2000 Left Ventricular Assist Device [J].
Gerosa, Gino ;
Gallo, Michele ;
Tarzia, Vincenzo ;
Di Gregorio, Guido ;
Zanella, Fabio ;
Bottio, Tomaso .
ANNALS OF THORACIC SURGERY, 2013, 96 (02) :712-714
[5]   In Vivo Experience of the Child-Size Pediatric Jarvik 2000 Heart: Update [J].
Gibber, Marc ;
Wu, Zhongjun J. ;
Chang, Won-Bae ;
Bianchi, Giacomo ;
Hu, Jingping ;
Garcia, Jose ;
Jarvik, Robert ;
Griffith, Bartley P. .
ASAIO JOURNAL, 2010, 56 (04) :369-376
[6]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[7]  
2-4
[8]   Jarvik 2000 Pump Technology and Miniaturization [J].
Jarvik, Robert .
HEART FAILURE CLINICS, 2014, 10 (01) :S27-+
[9]   Early in vivo experience with the pediatric Jarvik 2000 heart [J].
Kilic, Ahmet ;
Nolan, Timothy D. C. ;
Li, Tieluo ;
Yankey, G. Kwame ;
Prastein, Deyanira J. ;
Cheng, Guangming ;
Jarvik, Robert K. ;
Wu, Zhongjun J. ;
Griffith, Bartley P. .
ASAIO JOURNAL, 2007, 53 (03) :374-378
[10]   Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients [J].
Kirklin, James K. ;
Naftel, David C. ;
Kormos, Robert L. ;
Stevenson, Lynne W. ;
Pagani, Francis D. ;
Miller, Marissa A. ;
Baldwin, J. Timothy ;
Young, James B. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (02) :141-156